Are peptides legal in Ohio?

Short answer: Unapproved research peptides like BPC-157 and TB-500 cannot be lawfully sold or compounded for human use in Ohio, while FDA-approved peptide drugs such as semaglutide, tirzepatide, and prescription HGH are legal in Ohio only with a valid prescription filled by a licensed pharmacy, since Ohio has no peptide-specific statute and simply applies its general Board of Pharmacy and federal drug-approval/compounding rules to these substances.

Legal Status Overview

Gray Area

Ohio has no peptide-specific statute, administrative code section, or Board of Pharmacy rule that names 'peptides' or 'research chemicals' as a distinct legal category; instead, Ohio law regulates these substances the same way it regulates any other drug ingredient, through the Ohio Board of Pharmacy's licensing and compounding rules under Ohio Revised Code Chapter 4729 and Ohio Administrative Code Chapter 4729:5-3. Compounding of peptides by Ohio-licensed pharmacies is governed by the same federal 503A (traditional compounding) and 503B (outsourcing facility) framework that applies nationwide, meaning a peptide must either be FDA-approved or appear on FDA's 503A bulk drug substances list to be lawfully compounded for a patient. Because BPC-157 and TB-500 are not FDA-approved and are not on that bulks list, pharmacies cannot lawfully compound them for human dosing in Ohio, while FDA-approved peptide drugs (semaglutide, tirzepatide, somatropin/HGH) remain legal only as prescription medicines dispensed through licensed Ohio pharmacies.

Key Points

  • Ohio has no statute or Ohio Administrative Code rule that specifically names 'peptides' or 'research chemicals' as a distinct legal category; peptides fall under the state's general pharmacy and drug laws in Ohio Revised Code Chapter 4729. [1]
  • The Ohio Board of Pharmacy licenses and inspects pharmacies that compound drugs, applying compounding standards under Ohio Administrative Code Chapter 4729:5-3 that parallel the federal 503A/503B compounding framework. [2]
  • Under FDA's 503A framework, a pharmacy may only compound a drug from a bulk substance if that substance is FDA-approved or appears on FDA's 503A bulk drug substances list, and BPC-157 has not been added to that list. [3]
  • Semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) are FDA-approved prescription drugs, so in Ohio they can be legally obtained only with a valid prescription from a licensed prescriber, dispensed by an Ohio-licensed pharmacy. [4]
  • Human growth hormone (somatropin) is a prescription-only drug under federal law, and distributing it for any use other than an FDA-approved indication with a valid prescription is a federal criminal offense under 21 U.S.C. § 333(e), a rule Ohio pharmacies and prescribers must follow. [5]
  • A person cannot legally buy or bring unapproved research peptides like BPC-157 or TB-500 into Ohio for personal human use, because no Ohio Board of Pharmacy license or federal approval pathway authorizes their sale or compounding for that purpose; the only legal route to obtain peptide-class drugs in Ohio is a prescription from a licensed provider filled at a licensed pharmacy. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
  • Ohio has not enacted a peptide-specific criminal statute, so enforcement against unapproved research-peptide sales in Ohio generally proceeds through existing FDA misbranding/unapproved-new-drug authority and Ohio Board of Pharmacy licensing violations rather than a dedicated state peptide law. (No reliable source found for this point — flagged as unverified rather than stated as fact.)

Peptide-by-peptide status in Ohio

BPC-157 BPC-157 is not an FDA-approved drug and is not on FDA's 503A bulk drug substances list, so it cannot be lawfully compounded or dispensed for human use by Ohio-licensed pharmacies, leaving it in a legal gray zone typically sold as a 'research use only' chemical. [3]
Semaglutide / Tirzepatide (GLP-1 class) Semaglutide and tirzepatide are FDA-approved prescription medicines, so in Ohio they are legal only when prescribed by a licensed practitioner and dispensed through an Ohio-licensed pharmacy, with compounded copies restricted to the narrow drug-shortage exceptions under FDA's 503A/503B rules. [4]
TB-500 (Thymosin Beta-4) TB-500 has no FDA approval and is not listed on the 503A compounding bulks list, so like BPC-157 it cannot be legally compounded or sold for human use in Ohio and exists only as an unapproved research chemical. [3]
Human Growth Hormone (HGH/Somatropin) Somatropin is a federally controlled prescription drug, so in Ohio it is legal only when prescribed for an FDA-approved indication by a licensed provider and dispensed by a licensed pharmacy; distributing it for bodybuilding or anti-aging use without such a prescription is a federal crime. [5]

Sources

Last researched: 2026-09-09

Frequently asked questions

Can I buy peptides in Ohio without a prescription?

No -- in Ohio, FDA-approved peptide drugs like semaglutide, tirzepatide, and somatropin can only be legally obtained with a valid prescription filled at a licensed pharmacy, and unapproved research peptides like BPC-157 or TB-500 are not authorized for sale as human drugs at all, regardless of prescription. [4]

Is it legal to import or travel with peptides into Ohio for personal use?

There is no Ohio-specific personal-import allowance for peptides; bringing unapproved research peptides into Ohio for human use falls outside FDA's approved-drug and 503A/503B compounding framework, so it is not a clearly legal pathway, while FDA-approved peptide medicines require a valid prescription to be lawfully possessed.

Can an Ohio doctor prescribe peptides like BPC-157 through telehealth?

An Ohio-licensed prescriber can only lawfully prescribe FDA-approved peptide drugs (such as semaglutide or tirzepatide) via telehealth, but they cannot legally prescribe BPC-157 or TB-500 for human use because those compounds are not FDA-approved and are not on FDA's 503A bulk substances list for compounding. [3]

What happens if someone sells research-only peptides for human use in Ohio?

Selling or marketing an unapproved peptide such as BPC-157 for human use in Ohio can trigger enforcement under federal FDA unapproved-new-drug and misbranding authority, and any pharmacy involved in compounding it outside the 503A bulks list risks Ohio Board of Pharmacy licensing action, though Ohio has no dedicated state peptide-specific penalty statute.

Are compounded semaglutide or tirzepatide products still legal in Ohio?

Compounded semaglutide and tirzepatide are legal in Ohio only in narrow circumstances permitted under FDA's 503A/503B rules (such as during an FDA-declared drug shortage or for patient-specific medical needs like allergies to an approved product's ingredients), not as a general low-cost alternative to the FDA-approved brand products. [4]

Enforcement & Compliance

Note: This page provides general information based on the sourced research above. For specific legal questions in Ohio, consult with a licensed attorney familiar with pharmaceutical law.